Abstract:Treatment with epigallocatechin-3-gallate (EGCG), a polyphenolic compound of green tea, results in activation of p53 and induction of apoptosis in prostate cancer LnCaP cells. However, no direct evidence has delineated the role of p53 and p53-dependent pathways in EGCG-mediated apoptosis. To understand the mechanism of negative growth regulation of prostate cancer cells by EGCG we undertook a genetic approach and generated an isogenic pair of prostate carcinoma cells PC3 (p53-/-) by stably introducing a cDNA encoding wild-type p53. Treatment of the resultant cells, PC3-p53, with EGCG led to, as reported earlier in LnCaP cells, an increase in p53 protein, which exacerbated both G1 arrest and apoptosis. This response was accompanied by an increase in the levels of p21 and Bax. The cells lacking p53 continued to cycle and did not undergo apoptosis upon treatment with similar concentrations of EGCG, thus establishing the action of EGCG in a p53-dependent manner. This observation was revalidated in another prostate cancer LNCaP cells harboring wild-type p53. Inactivation of p53 using small interfering RNA (siRNA) rendered these cells resistant to EGCG-mediated apoptosis. Because p53 activation led to increase in p21 and Bax, we investigated whether these two proteins are important in this process. Ablation of p21 protein by siRNA prevented G1 arrest and apoptosis in PC3-p53 cells. The p53-dependent increase in Bax expression altered the Bax/Bcl-2 ratio and paralleled the activation of caspase 9 and 3 and cleavage of PARP. Transfection of cells with Bax siRNA abolished these effects and inhibited apoptosis but did not affect the accumulation of the cells in G1. In summary, using isogenic cell lines and siRNA, we have clearly demonstrated that EGCG activates growth arrest and apoptosis primarily via p53-dependent pathway that involves the function of both p21 and Bax such that down-regulation of either molecule confers a growth advantage to the cells.

A Component of Green Tea, (-)-epigallocatechin-3-gallate, Promotes Apoptosis in T24 Human Bladder Cancer Cells Via Modulation of the PI3K/Akt Pathway and Bcl-2 Family Proteins

Growth Inhibition of Prostate Cancer Cells by Epigallocatechin Gallate in the Presence of Cu<sup>2+</sup>

Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.

Epigallocatechin Gallate Inhibits the Growth and Promotes the Apoptosis of Bladder Cancer Cells

Epigallocatechin-3-gallate Inhibits Bladder Cancer Cell Invasion Via Suppression of NF-κB‑mediated Matrix Metalloproteinase-9 Expression.

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

Growth Inhibition Of Prostate Cancer Cells By Epigallocatechin Gallate In The Presenceof Cu2+

Effects of EGCG on Apoptosis of Human Bladder Carcinoma T24 Cells

EGCG Inhibited Bladder Cancer SW780 Cell Proliferation and Migration Both in Vitro and in Vivo Via Down-Regulation of NF-κB and MMP-9

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells

(‑)‑Epigallocatechin‑3‑gallate Inhibits Bladder Cancer Stem Cells Via Suppression of Sonic Hedgehog Pathway.

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer

Role of Ku70 and Bax in epigallocatechin-3-gallate-induced apoptosis of A549 cells in vivo.

(-)-Epigallocatechin-3-gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells Via Ros-Mediated Lysosomal Membrane Permeabilization

Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase

Green tea and tea polyphenols in cancer prevention.

Epigallocatechin Gallate, the Main Ingredient of Green Tea Induces Apoptosis in Breast Cancer Cells.

Ablation of either p21 or Bax prevents p53‐dependent apoptosis induced by green tea polyphenol epigallocatechin‐3‐gallate

Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer

Green Tea Catechins: a Fresh Flavor to Anticancer Therapy.

Green tea constituent (−)-Epigallocatechin-3-gallate inhibits hep G2 cell proliferation and induces apoptosis through p53-dependent and fas-mediated pathways